Lenz Robert A. 4
4 · Neumora Therapeutics, Inc. · Filed Feb 16, 2024
Insider Transaction Report
Form 4
Lenz Robert A.
Head of R&D
Transactions
- Award
Common Stock
2024-02-14+50,000→ 402,941 total - Award
Stock Option (Right to Buy)
2024-02-14+100,000→ 100,000 totalExercise: $18.07Exp: 2034-02-13→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 25% of the RSUs vest annually measured from February 14, 2024 (the "Vesting Commencement Date"), such that 100% of the RSUs will be fully vested on the fourth anniversary of the Vesting Commencement Date.
- [F2]25% of the shares subject to the option vest on the first anniversary measured from February 14, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.